Immuno Oncology Talks

Adoptive therapy with engineered T cell receptors

Hematology, Science

25 tammikuun, 2023


Prof., Reno Debets

In the current, and fifth episode of the “Immuno Oncology Talks”, we discuss adoptive therapy with engineered T cell receptors, with Professor Reno Debets from the Erasmus MC Cancer Institute in the Netherlands. Professor Debets research aims to explore therapeutic strategies by developing and testing adoptive T cell therapy and understand and intervene with the cross-talk between tumor cells and T cells.

For more information please visit:
Sanofi Immuno Oncology Talks website

Share this podcast with your colleagues

MAT-BE-2300064 (Ver 1.0) Jan 2023